Nuclear survivin and its relationship to DNA damage repair genes in non-small cell lung cancer investigated using tissue array.
Texto
Documentos relacionados
These findings may explain why patients in our study whose tumors expressed NY-ESO-1 had significantly improved responses to neoadjuvant chemotherapy and yet no survival benefit
In addition, a very high incidence of LOH (75%) was observed upon analysis of a SNP located within the ADAR2 gene. These results can be explained by the existence of alternating
In addition, the expression level of TRPC channels may depend on the differentiation status of the cancer cells, because we found the mRNA expression of TRPC1, TRPC3, TRPC4 and TRPC6
Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients.. Bernd Schmidt 1 , Julia
Other studies, using the monoclonal antibody 8F1[43] have reported that the presence of ERCC1 protein is a prognostic marker of survival in early NSCLC and a predictor of outcome
Finally, we report that new candidate miRNAs which can regulate cell cycle progression in human non-small cell lung cancer cell lines. It is still an open question that whether
In lung cancer, several miRNA expression profiles have been identified with remarkably high predictive values including a 34-miRNA diagnostic signa- ture with an AUC of 0.89 [9],
Among NSCLC patients, after adjusting for age, female gender and adenocarcinoma, being a never-smoker with early treatment of the disease and having a higher Karnofsky